Mental capacity disorders under stress and their correction
- Authors: Sokolova L.P.1, Knyazev I.V.2,1, Sukhareva Y.A.1
-
Affiliations:
- Clinical Нospital № 1 of Department for Presidential Affairs of the Russian Federation
- Central State Medical Academy of Department for Presidential Affairs of the Russian Federation
- Issue: No 4 (2016)
- Pages: 122-126
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277536
- ID: 277536
Cite item
Open Access
Access granted
Abstract
In recent years idea of cognitive disorders as civilization diseases, included in the structure of psychosomatic diseases, neuroses, is becoming increasingly popular. The causes of functional cognitive disorders (FCD) due to stress are: sleep disturbances, irrational use of psychotropic medications, emotional and personality disorders, information neurosis, etc. In the study involving 25 patients with mild and moderate FCD on the background of stress, defining characteristics of their neuropsychological cognitive status and complaints were determined. It was found that FCD affect, as a rule, patients with a high level of personal anxiety, with a high level of motivation and ambition. In the treatment of FCD of the stress should be given preference for the correction of mental and emotional status, and sleep disorders. It is advisable to use the drug Pantocalcin (calcium hopantenate) - GABAergic nootropic drug, possessing both sedative and mild stimulating effect.
Full Text
About the authors
Lyubov Petrovna Sokolova
Clinical Нospital № 1 of Department for Presidential Affairs of the Russian Federation
Email: lsocolova@yandex.ru
MD, neurologist of the highest category, consultant of Outpatient Department
Irina Vladimirovna Knyazev
Central State Medical Academy of Department for Presidential Affairs of the Russian Federation; Clinical Нospital № 1 of Department for Presidential Affairs of the Russian Federation
Email: irina_knyazeva@list.ru
postgraduate student, Department of neurology; neurologist of Outpatient Department
Yelena Aleksandrovna Sukhareva
Clinical Нospital № 1 of Department for Presidential Affairs of the Russian Federation
Email: plk_vol@mail.ru
therapist of the highest category, Head of the policlinic
References
- Бурчинский С.Г. Возможности дальнейшей оптимизации фармакотерапии и фармакопрофилактики когнитивных расстройств. Новости медицины и фармации. 2014;20(522):3-6. [Burchinsky S.G. Opportunities to further optimization of pharmacotherapy and prevention of cognitive disorders. News of medicine and pharmacy. 2014;20(522):3-6 (in Russian)]
- Дамулин И.В. Деменции у пациентов молодого и среднего возраста. Некоторые клинические, диагностические и терапевтические аспекты. М.: 2011. 40 с. [Damulin I.V. Dementia in patients of young and middle age. Some clinical, diagnostic and therapeutic aspects. Moscow: 2011. 40 p. (in Russian)]
- Левин О.С. Диагностика и лечение деменции в клинической практике. М.: МЕДпресс-информ, 2010. 256 с. [Levin O.S. Diagnostics and treatment of dementia in clinical practice. Moscow: MEDpress-inform, 2010. 256 p. (in Russian)]
- Моргунов Л.Ю. Диабетическая энцефалопатия. Амбулаторный прием, клинические рекомендации по ведению больных. 2014:40-44. [Morgunov L.Yu. Diabetic encephalopathy. Outpatient care, clinical practice guidelines for the management of patients. 2014:40-44 (in Russian)]
- Соколова Л.П. Функциональные когнитивные расстройства. Врач. 2011;7:10-2. [Sokolova L.P. Functional cognitive disorders. Doctor. 2014:40-44 (in Russian)]
- Спирин Н.Н., Александров Ю.К., Касаткина Е.Л., Ширманова Е.В. Неврологические аспекты нарушения функции щитовидной железы. Методическое пособие. Ярославль: Ремдер, 2007. 40 с. [Spirin N.N., Aleksandrov Yu.K., Kasatkina Ye.L., Shirmanova Ye.V. Neurological aspects of disorders of thyroid function. Methodical manual. Yaroslavl: Remder, 2007. 40 p. (in Russian)]
- Яхно Н.Н. Неврологические расстройства в неврологической клинике. Неврологический журнал. 2006;11 (Прил. 1):4-12. [Yakhno N.N. Neurological disorders in the neurological clinic. Neurological journal. 2006;11 (Suppl. 1):4-12 (in Russian)]
- Golomb J., Kluger A., Garrard P., Ferris S. Clinicians manual on mild cognitive impairment. London: Science Press, 2001.
- Greenberg D.A., Aminoff M.J., Simon R.P. Clinical Neurology. 5th edition. Chapter 1: Disorders of consciousness. New York etc.: Lange Medical Books/McGraw-Hill, 2002. P. 1-70.
- Lovenstone S., Gauthier S. Management of dementia. London: Martin Dunitz, 2001.
- McCombe P. Toxic and deficiency states. In: Drug Therapy in Neurology. Ed. by M.J. Eadie. Chapter 20. Edinburgh etc.: Churchill Livingstone, 1992. P. 549-71.
- Инструкция по медицинскому применению препарата Пантокальцин. [Instructions for medical use of the drug Pantokaltsin (in Russian)]
- Муратова Н.В. Пантокальцин: области клинического применения. РМЖ. 2007;9(10):868-73. [Muratova N. In. Pantokaltsin: clinical applications. Russian medical journal. 2007;9(10):868-73 (in Russian)]
- Камчатнов П.Р. Счастье - это хорошее здоровье и плохая память?! Современные возможности повышения качества жизни пациента. Эффективная фармакотерапия. 2015;23:82-5. [Kamchatnov P.R. Happiness is good health and a bad memory?! Modern possibilities of increasing patient's life quality. Effective pharmacotherapy. 2015;23:82-5 (in Russian)]
Supplementary files
